Furthermore, miR‐105 acts as a tumor suppressor in hepatocellular carcinoma via inhibiting the phosphatidylinositol 3‐kinase (PI3K)/AKT signaling pathway. The gene discussed is AKT1; the disease is hepatocellular carcinoma.